The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

There is currently no screening programme for prostate cancer, the most common cancer in men. But there has been some energetic campaigning for change by high-profile figures, including Sir Chris Hoy, ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 cases and less progress in mortality, even as other experts disagree and cite ...

WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant prostate cancer have many effective treatment options, but questions remain ...

It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision ...